MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the …
MGX Investors, pay attention! You have the opportunity to take the lead on a securities fraud lawsuit involving Metagenomi, Inc. in collaboration with the Schall Law Firm. This national shareholder rights litigation firm has filed a class action lawsuit against Metagenomi, Inc. (NASDAQ: MGX) for alleged violations of federal securities laws.
If you purchased securities from Metagenomi, Inc. during its initial public offering (“IPO”) conducted on or about February 9, 2024, and have suffered losses, you are urged to get in touch with the firm before November 25, 2024. Shareholders who have experienced losses can participate by following the link provided.
To discuss your rights free of charge, contact Brian Schall at the Schall Law Firm located in Los Angeles, California. Although the class has not yet been certified, not taking any action could mean you remain an absent class member.
The lawsuit alleges that Metagenomi, Inc. made false and misleading statements about its business relationship with Moderna during the IPO period. These claims were based on a Strategic Collaboration and License Agreement made in October 2021. However, just months after the IPO, Metagenomi, Inc. announced the termination of their collaboration with Moderna. As a result, investors suffered damages when the truth came to light.
The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation and represents investors worldwide. Remember that this information may be deemed Attorney Advertising in some jurisdictions.
Take action now to recover your losses and learn more about this ongoing lawsuit. Contact the Schall Law Firm for more information.
